The complexity of sunitinib dosing in renal cell cancer patients

Yazar: Desar, Ingrid M.E., Mulder, Sasja F., Mulders, Peter F.A., van Herpen, Carla M.L.
Yayımlandı Transl Androl Urol (2012)

Theranostic applications of antibodies in oncology

Yazar: Fleuren, Emmy D.G., Versleijen-Jonkers, Yvonne M.H., Heskamp, Sandra, van Herpen, Carla M.L., Oyen, Wim J.G., van der Graaf, Winette T.A., Boerman, Otto C.
Yayımlandı Mol Oncol (2014)

(68)Ga-PSMA-HBED-CC PET/CT imaging for adenoid cystic carcinoma and salivary duct carcinoma: a phase 2 imaging study

Yazar: van Boxtel, Wim, Lütje, Susanne, van Engen-van Grunsven, Ilse C.H., Verhaegh, Gerald W., Schalken, Jack A., Jonker, Marianne A., Nagarajah, James, Gotthardt, Martin, van Herpen, Carla M.L.
Yayımlandı Theranostics (2020)

Impairment of cognitive functioning during Sunitinib or Sorafenib treatment in cancer patients: a cross sectional study

Yazar: Mulder, Sasja F, Bertens, Dirk, Desar, Ingrid ME, Vissers, Kris CP, Mulders, Peter FA, Punt, Cornelis JA, van Spronsen, Dick-Johan, Langenhuijsen, Johan F, Kessels, Roy PC, van Herpen, Carla ML
Baskı/Yayın Bilgisi 2014

Experimental treatment of NRAS-mutated neurocutaneous melanocytosis with MEK162, a MEK-inhibitor

Yazar: Küsters-Vandevelde, Heidi VN, Willemsen, Annelieke ECAB, Groenen, Patricia JTA, Küsters, Benno, Lammens, Martin, Wesseling, Pieter, Djafarihamedani, Melika, Rijntjes, Jos, Delye, Hans, Willemsen, Michel A, van Herpen, Carla ML, Blokx, Willeke AM
Baskı/Yayın Bilgisi 2014

Merkel Cell Carcinoma: New Trends

Yazar: Zwijnenburg, Ellen M., Lubeek, Satish F.K., Werner, Johanna E.M., Amir, Avital L., Weijs, Willem L.J., Takes, Robert P., Pegge, Sjoert A.H., van Herpen, Carla M.L., Adema, Gosse J., Kaanders, Johannes H. A. M.
Yayımlandı Cancers (Basel) (2021)

Cisplatin inhibits frequency and suppressive activity of monocytic myeloid-derived suppressor cells in cancer patients

Yazar: Van Wigcheren, Glenn F., De Haas, Nienke, Mulder, Tom A., Horrevorts, Sophie K., Bloemendal, Martine, Hins-Debree, Simone, Mao, Yumeng, Kiessling, Rolf, van Herpen, Carla M.L., Flórez-Grau, Georgina, Hato, Stanleyson V., De Vries, I. Jolanda M.
Yayımlandı Oncoimmunology (2021)

Humoral and cellular immune responses after influenza vaccination in patients with postcancer fatigue

Yazar: Prinsen, Hetty, van Laarhoven, Hanneke WM, Pots, Jeanette M, Duiveman-de Boer, Tjitske, Mulder, Sasja F, van Herpen, Carla ML, Jacobs, Joannes FM, Leer, Jan Willem H, Bleijenberg, Gijs, Stelma, Foekje F, Torensma, Ruurd, de Vries, I Jolanda M
Yayımlandı Hum Vaccin Immunother (2015)

Biomarker results from a phase II study of MEK1/2 inhibitor binimetinib (MEK162) in patients with advanced NRAS- or BRAF-mutated melanoma

Yazar: van Herpen, Carla M.L., Agarwala, Sanjiv S., Hauschild, Axel, Berking, Carola, Beck, J. Thaddeus, Schadendorf, Dirk, Jansen, Rob, Queirolo, Paola, Ascierto, Paolo A., Blank, Christian U., Heinrich, Michael C., Pal, Rupam R., Derti, Adnan, Antona, Victor, Nauwelaerts, Heidi, Zubel, Angela, Dummer, Reinhard
Yayımlandı Oncotarget (2019)

Platinum-based drugs disrupt STAT6-mediated suppression of immune responses against cancer in humans and mice

Yazar: Lesterhuis, W. Joost, Punt, Cornelis J.A., Hato, Stanleyson V., Eleveld-Trancikova, Dagmar, Jansen, Bastiaan J.H., Nierkens, Stefan, Schreibelt, Gerty, de Boer, Annemiek, Van Herpen, Carla M.L., Kaanders, Johannes H., van Krieken, Johan H.J.M., Adema, Gosse J., Figdor, Carl G., de Vries, I. Jolanda M.
Baskı/Yayın Bilgisi 2011

Direct inhibition of STAT signaling by platinum drugs contributes to their anti-cancer activity

Yazar: Hato, Stanleyson V., Figdor, Carl G., Takahashi, Susumu, Pen, Anja E., Halilovic, Altuna, Bol, Kalijn F., Vasaturo, Angela, Inoue, Yukie, de Haas, Nienke, Verweij, Dagmar, Van Herpen, Carla M.L., Kaanders, Johannes H., van Krieken, Johan H.J.M., Van Laarhoven, Hanneke W.M., Hooijer, Gerrit K.J., Punt, Cornelis J.A., Asai, Akira, de Vries, I. Jolanda M., Lesterhuis, W.J.
Yayımlandı Oncotarget (2017)